SCHEMBL17191644

SCHEMBL17191644

CC[C@H]1O[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@H]1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ OGA O60502 1/20 0.43
▸ CYP2D6 P10635 2/20 0.42
▸ THRB P10828 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ CA2 P00918 2/20 0.40
▸ NR3C1 P04150 1/20 0.35
▸ FYN P06241 1/20 0.35
▸ ADRA2A P08913 1/20 0.35
▸ ADORA3 P0DMS8 1/20 0.35
▸ ADRA2B P18089 1/20 0.35
▸ DRD4 P21917 1/20 0.35
▸ DRD3 P35462 1/20 0.35
▸ P4HB P07237 1/20 0.35
▸ PDIA4 P13667 1/20 0.35
▸ PDIA3 P30101 1/20 0.35
▸ LMNA P02545 1/20 0.34
▸ BCHE P06276 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ CA9 Q16790 2/20 0.33
▸ CA12 O43570 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17521955 1.00 OGA (0.43) OGACYP2D6THRBHSD17B10CA2
SCHEMBL19770015 1.00 OGA (0.43) OGACYP2D6THRBHSD17B10CA2
SCHEMBL15982017 1.00 OGA (0.43) OGACYP2D6THRBHSD17B10CA2
SCHEMBL12958081 1.00 OGA (0.43) OGACYP2D6THRBHSD17B10CA2
SCHEMBL16259299 1.00 OGA (0.43) OGACYP2D6THRBHSD17B10CA2
SCHEMBL25480878 1.00 OGA (0.43) OGACYP2D6THRBHSD17B10CA2
SCHEMBL25763672 1.00 OGA (0.43) OGACYP2D6THRBHSD17B10CA2
SCHEMBL19798073 1.00 OGA (0.43) OGACYP2D6THRBHSD17B10CA2
SCHEMBL10024713 0.95 OGA (0.41) OGACYP2D6THRBHSD17B10CA2
SCHEMBL16923234 0.95 OGA (0.41) OGACYP2D6THRBHSD17B10CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9593362-B2 Fluorogenic glycosidase substrate and associated detection method ECOLE NORMALE SUPERIEURE DE LYON (FR) 2017-03-14 — — US disclosed
US-20150299762-A1 FLUOROGENIC GLYCOSIDASE SUBSTRATE AND ASSOCIATED DETECTION METHOD ECOLE NORMALE SUPERIEURE DE LYON (FR) 2015-10-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150299762-A1 FLUOROGENIC GLYCOSIDASE SUBSTRATE AND ASSOCIATED DETECTION METHOD MAN2B1, FUCA1, NEU1 OGA 379/4885CYP2D6 630/4885THRB 2565/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback